TAMPA, Fla. (AP) — TAMPA, Fla. (AP) — Oragenics Inc. (OGEN) on Thursday reported a loss of $2 million in its third quarter.
The Tampa, Florida-based company said it had a loss of 85 cents per …
Join our family of readers for as little as $5 per month and support local, unbiased journalism.
Already have an account? Log in to continue. Otherwise, follow the link below to join.
Please log in to continue |
TAMPA, Fla. (AP) — TAMPA, Fla. (AP) — Oragenics Inc. (OGEN) on Thursday reported a loss of $2 million in its third quarter.
The Tampa, Florida-based company said it had a loss of 85 cents per share.
The oral health ad antibiotics company posted revenue of $7,500 in the period. Its adjusted revenue was $7,000.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OGEN at https://www.zacks.com/ap/OGEN
